Efficacy of BCG vaccination on incidence, severity and clinical progression of COVID-19: A BCG-REVAC population analysis
Even 23 years after BCG vaccination and revaccination of school-age children our results suggesting a protective effect of BCG first dose against incidence of severe COVID-19 in infected individuals, a smaller effect of the neonatal dose and no effect of the second dose at school age.
Authors
- Maria Yury Ichihara (ORCID: https://orcid.org/0000-0001-8590-6212)
- Marcos Pereira (ORCID: https://orcid.org/0000-0003-3766-2502)
- Laura C. Rodrigues (ORCID: https://orcid.org/0000-0001-9008-660X)
- Bernd Genser (ORCID: https://orcid.org/0000-0001-5787-0902)
- Maurício L. Barreto (ORCID: https://orcid.org/0000-0002-0215-4930)
- Carlos Antônio de Souza Teles Santos (ORCID: https://orcid.org/0000-0003-0970-0479)
- Susan Martins Pereira (ORCID: https://orcid.org/0000-0001-5291-454X)
- Carla Cristina Oliveira de Jesus Lima (ORCID: https://orcid.org/0000-0002-0555-5115)
- Daniel Barros de Castro
- Márcio Natividade (ORCID: https://orcid.org/0000-0002-3986-5656)
- Ramon Andrade de Souza
- Florisneide Rodrigues Barreto
Institutions
- University of London (GB)
- Universidade Federal da Bahia (BR)
- Fundação de Medicina Tropical (BR)
- Knowledge Integration (United Kingdom) (GB)
- Fundação Oswaldo Cruz (BR)
Publication Details
- Journal
- Vaccine
- Published
- 2025-03-09
- DOI
- https://doi.org/10.1016/j.vaccine.2025.126911
- Citations
- 2
- Primary Topic
- Immune responses and vaccinations
- Type
- article
- Field-Weighted Citation Impact
- 1.59
Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico